We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.45B
AUM Growth
+$284M
Cap. Flow
-$20.5M
Cap. Flow %
-0.46%
Top 10 Hldgs %
34.33%
Holding
1,079
New
59
Increased
179
Reduced
284
Closed
85

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$41.1M
2
ADBE icon
Adobe
ADBE
+$23M
3
NSC icon
Norfolk Southern
NSC
+$13.8M
4
META icon
Meta Platforms (Facebook)
META
+$10.6M
5
OTIS icon
Otis Worldwide
OTIS
+$6.73M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
CVS icon
CVS Health
CVS
+$24.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$16.5M
4
UNH icon
UnitedHealth
UNH
+$14.5M
5
NVDA icon
NVIDIA
NVDA
+$6.26M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Healthcare 16.06%
3 Financials 12.32%
4 Consumer Discretionary 10.19%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKNG icon
376
Booking.com
BKNG
$138B
$192K ﹤0.01%
1,775
– –
BR icon
377
Broadridge
BR
$17.2B
$189K ﹤0.01%
1,143
– –
GL icon
378
Globe Life
GL
$13.5B
$187K ﹤0.01%
1,709
+696
+69% +$74.8K
RJF icon
379
Raymond James Financial
RJF
$32.5B
$187K ﹤0.01%
1,800
+177
+11% +$16.4K
CME icon
380
CME Group
CME
$92.2B
$187K ﹤0.01%
1,008
-349
-26% -$64.5K
EQIX icon
381
Equinix
EQIX
$107B
$186K ﹤0.01%
237
+87
+58% +$63.7K
VBK icon
382
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$186K ﹤0.01%
808
– –
HIW icon
383
Highwoods Properties
HIW
$3.71B
$184K ﹤0.01%
7,700
– –
ES icon
384
Eversource Energy
ES
$28.2B
$184K ﹤0.01%
2,595
-725
-22% -$54K
FEX icon
385
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.58B
$183K ﹤0.01%
2,180
– –
IWN icon
386
iShares Russell 2000 Value ETF
IWN
$14.4B
$183K ﹤0.01%
1,299
– –
A icon
387
Agilent Technologies
A
$39.1B
$178K ﹤0.01%
1,483
– –
FCN icon
388
FTI Consulting
FCN
$4.82B
$178K ﹤0.01%
936
– –
DXCM icon
389
DexCom
DXCM
$27.6B
$175K ﹤0.01%
1,364
+200
+17% +$24.2K
BN icon
390
Brookfield
BN
$102B
$175K ﹤0.01%
7,800
– –
IBB icon
391
iShares Biotechnology ETF
IBB
$9.31B
$175K ﹤0.01%
1,375
– –
PEN icon
392
Penumbra
PEN
$12.5B
$172K ﹤0.01%
500
– –
OKTA icon
393
Okta
OKTA
$24.1B
$172K ﹤0.01%
2,478
– –
ET icon
394
Energy Transfer Partners
ET
$70.1B
$171K ﹤0.01%
13,442
– –
AZN icon
395
AstraZeneca
AZN
$263B
$169K ﹤0.01%
1,180
+140
+13% +$20.6K
XLK icon
396
State Street Technology Select Sector SPDR ETF
XLK
$115B
$168K ﹤0.01%
1,936
– –
EL icon
397
Estee Lauder
EL
$29B
$168K ﹤0.01%
854
-201
-19% -$42.6K
CTSH icon
398
Cognizant
CTSH
$21.5B
$166K ﹤0.01%
2,550
-297
-10% -$18.4K
WBA
399
DELISTED
Walgreens Boots Alliance
WBA
$166K ﹤0.01%
5,830
-871
-13% -$28.4K
JEF icon
400
Jefferies Financial Group
JEF
$12.9B
$163K ﹤0.01%
4,925
+3,700
+302% +$115K
14 15
16
17 18

Similar funds

AIM
Adapt Investment Managers Geneva, Switzerland $7.56B AUM 29.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return
SP
SIH Partners Wilmington, Delaware $7.58B AUM 5.28% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return

HM Payson & Co's Q2 2023 Portfolio in Review

As of Q2 2023, HM Payson & Co held 1,079 positions worth $4.45B, up 6.8% from $4.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

HM Payson & Co's Q2 2023 filing shows 59 new, 179 increased, 284 reduced and 85 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M. The largest sale was Pfizer, an estimated $30M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2023 buy was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M.
  • HM Payson & Co added most to Marathon Petroleum in Q2 2023, an estimated $41.1M increase.
  • HM Payson & Co's biggest Q2 2023 reduction was Pfizer, cutting an estimated $30M.
  • HM Payson & Co fully exited Vanguard Short-Term Bond ETF in Q2 2023, selling an estimated $3.44M.
  • HM Payson & Co's ten largest holdings make up 34% of its $4.45B portfolio in Q2 2023.
  • HM Payson & Co opened 59 new positions and closed 85 in Q2 2023.
  • HM Payson & Co's portfolio value rose 6.8% quarter-over-quarter to $4.45B.

Based on HM Payson & Co's 13F filing for Q2 2023, filed 17 Jul 2023.